A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

  • USD3.01
  • USD3.07
  • USD2.98
  • USD3.22
  • 13.20%
  • 51M
  • 615.57k
  • 1.11M
  • 488M
  • 1.85
  • -0.70%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.